Table 3. Univariate and multivariate analysis of factors related to disease-free survival (DFS) in breast cancer patients.
| Variables | DFS | |||
|---|---|---|---|---|
| Univariate Analysis | Multivariate Analysis | |||
| HR(95% CIs) | P | HR(95% CIs) | P | |
| Age | 0.815(0.552-1.534) | 0.939 | 0.971(0.554-1.700) | 0.917 |
| Histological grade | 1.761(1.041-2.980) | 0.035 | 1.749(0.965-3.170) | 0.065 |
| Tumor Size | 1.715(1.086-2.708) | 0.021 | 1.648(1.042-2.606) | 0.033 |
| Metastatic nodes | 2.231(1.304-3.819) | 0.003 | 2.158(1.236-3.769) | 0.007 |
| ER | 0.786(0.456-1.356) | 0.388 | 1.491(0.713-3.117) | 0.288 |
| PR | 0.408(0.185-0.903) | 0.027 | 0.372(0.144-0.960) | 0.041 |
| HER-2 | 0.936(0.548-1.600) | 0.809 | 0.754(0.412-1.378) | 0.358 |
| BCDIN3D | 1.754(1.012-3.039) | 0.045 | 1.904(1.081-3.354) | 0.026 |
Abbreviations: HR, hazard ratio; CIs, confidence intervals; ER, estrogen receptor; PR, progesterone receptor; HER-2, human epidermal growth factor receptor 2;